page contents

sites

Tuesday 7 May 2013

Metastatic CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer Biography

Source(google.com.pk)

Bio-Nucleonics, Inc., a life sciences Company, specializing in the development and manufacture of radiopharmaceuticals, medical devices and imaging agents, will be attending the Society of Nuclear Medicine (SNM) Annual Meeting, held in San Antonio, TX, June 4th through 8th, 2011.

The Company announced that it has resumed production of the cancer drug Strontium Chloride Sr-89 Injection USP ("Strontium-89"). Strontium-89 is an intravenously administered cancer drug that provides long lasting pain relief for patients suffering from bone pain due to metastatic cancer, typically caused by advanced stage breast, prostate or lung cancer.

Strontium-89 is preferentially absorbed in bone metastases, providing a long-term effect resulting in an enhanced quality-of-life. There are approximately 300,000 new cases per year in the U.S., an area of unmet medical need. It has been reported that there is a decrease in pain, an increase in physical activity and a reduction in the need for opiate analgesics, such as morphine, in up to 80% of patients.

President and Chief Executive Officer Roseanne Satz stated, "Our participation at SNM is crucial to meeting with our radiopharmacy customers and creating market awareness. The exposure and introductions gained from these industry conferences yield opportunities that advance our future growth. We are pleased to be able to fill the demand for this important drug which allows greater flexibility in pain management and improves patient quality-of-life."

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 Metastatic Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

Cancer InstitudSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud Biography

Source(google.com.pk)

Harold Varmus, M.D., co-recipient of a Nobel Prize for studies of the genetic basis of cancer, was nominated by President Obama as Director of the National Cancer Institute on May 17, 2010. He began his tenure as NCI Director on July 12, 2010. He previously served as President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center Exit Disclaimer (MSKCC) and as Director of the National Institutes of Health (NIH).

Much of Varmus' scientific work was conducted during 23 years as a faculty member at the University of California, San Francisco, Medical School, where he and Dr. J. Michael Bishop and their co-workers demonstrated the cellular origins of the oncogene of a chicken retrovirus. This discovery led to the isolation of many cellular genes that normally control growth and development and are frequently mutated in human cancer. For this work, Bishop and Varmus received many awards, including the 1989 Nobel Prize for Physiology or Medicine. Varmus is also widely recognized for his studies of the replication cycles of retroviruses and hepatitis B viruses, the functions of genes implicated in cancer, and the development of mouse models of human cancer (the focus of much of the work in his laboratory at MSKCC).

In 1993, Varmus was named by President Clinton to serve as the Director of NIH, a position he held until the end of 1999. During his tenure at NIH, he initiated many changes in the conduct of intramural and extramural research programs; recruited new leaders for most of the important positions at NIH; planned three major buildings on the NIH campus, including the Mark O. Hatfield Clinical Research Center ; and helped to initiate the five-year doubling of the NIH budget.

At MSKCC, Varmus emphasized opportunities to harness advances in the biological sciences to improve the care of patients with cancer. Under his leadership, the scientific programs were reorganized and enlarged; a new research building, the Mortimer B. Zuckerman Research Center, was constructed; and new graduate training programs were established in chemical biology and computational biology (as part of a new Tri-Institutional Research Program with Rockefeller University and Weill-Cornell Medical College) and in cancer biology (through MSKCC's first degree-awarding program in the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences).

In addition, he oversaw the construction of new clinical facilities (for pediatrics, pathology, urology, and surgery) and new centers for breast cancer treatment and imaging Exit Disclaimer (the Evelyn H. Lauder Breast Center and the MSKCC Imaging Center); the founding of a hospital-based program in translational research (the Human Oncology and Pathogenesis Program Exit Disclaimer); and the development of the Tri-Institutional Stem Cell Initiative and the Starr Cancer Consortium, involving five research institutions. To ensure that MSKCC was promoting high-quality cancer care for all citizens of New York and equal opportunities for its employees, he helped to found and oversee a new cancer clinic in central Harlem (the Ralph Lauren Center for Cancer Care and Prevention) and new programs for diversity and gender equity (the Office of Diversity Programs in Clinical Care, Research, and Training and the Women Faculty Affairs Program).

Varmus has authored over 300 scientific papers and five books, including an introduction to the genetic basis of cancer for a general audience and a memoir, The Art and Politics of Science, published in 2009. He has been an advisor to the Federal government, pharmaceutical and biotechnology firms, and many academic institutions, and was appointed by President Barack Obama as co-chair of the President's Council of Advisors on Science and Technology (PCAST). He served on the World Health Organization's Commission on Macroeconomics and Health from 2000 to 2002; is a co-founder and Chairman of the Board of Directors of the Public Library of Science, a publisher of open-access journals in the biomedical sciences; chaired the Scientific Board of the Grand Challenges in Global Health at the Bill and Melinda Gates Foundation from 2003 to 2008 and now chairs the Foundation's Global Health Advisory Committee; and is involved in several initiatives to promote science in developing countries, including the Global Science Corps, through the Science Initiatives Group. He was also a member of the Funding Committee of the Empire State Stem Cell Board and serves as co-chair of the Institute of Medicine's committee on "The U.S. Commitment to Global Health." He has been a member of the U.S. National Academy of Sciences Exit Disclaimer since 1984 and of the Institute of Medicine Exit Disclaimer since 1991, and has received the National Medal of Science, the Vannevar Bush Award, and several honorary degrees and other prizes, in addition to the Nobel Prize.

A native of Freeport, Long Island, Varmus is the son of Dr. Frank Varmus, a general practitioner, and Beatrice Varmus, a psychiatric social worker. After graduating from Freeport High School, he majored in English literature at Amherst College and earned a master's degree in English at Harvard University. He is a graduate of Columbia University's College of Physicians and Surgeons, worked as a medical student in a hospital in India, and served on the medical house staff at Columbia-Presbyterian Medical Center. He began his scientific training as a Public Health Service officer at NIH, where he studied bacterial gene expression with Dr. Ira Pastan, and then trained as a post-doctoral fellow with Dr. Bishop at the University of California, San Francisco.

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer Insitud

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

 

Brain CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer Biography

Source(google.com.pk)
Genentech BioOncology is dedicated to advancing the science of glioblastoma therapy through comprehensive research programs and education. Glioblastomas usually form in astrocytes in the cerebral white matter.1
Glioblastoma Demographic Statistics

    In 2004–2007, an estimated 37,890 Americans were diagnosed with glioblastoma—16.7% of all reported brain tumors2

    Most brain tumors are not associated with known risk factors.1 However, risk factors include ionizing radiation exposure to the head and a family history of inherited conditions such as neurofibromatosis type 1 and Li-Fraumeni syndrome1,3
    The 5-year survival rate for patients with glioblastoma is 2.9%4
    The median survival time for glioblastoma is limited to approximately 10 to 15 months5

Symptoms of glioblastoma include headache; nausea; vomiting; blurred vision; balance problems; drowsiness; seizure; hemiparesis; and progressive memory, personality, or neurologic deficits.1,3
Other links to glioblastoma disease information

These links give a sampling of other sites offering information on glioblastoma, which you may find useful in your practice.

    National Cancer Institute at National Institutes of Health, Brain Tumor
    ASCO Cancer Portals - Head & Neck Cancers
    Cancer Facts & Figures

Unless otherwise indicated, Genentech, Inc. is neither affiliated with nor endorses any of the organizations listed.

    American Cancer Society. Brain and spinal cord tumors in adults. www.cancer.org/Cancer/BrainCNSTumorsinAdults/DetailedGuide/brain-and-spinal-cord-tumors-in-adults-what-is-cancer. Accessed April 14, 2011.

    CBTRUS (2011). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. Web site: www.cbtrus.org. Accessed April 13, 2011.

    US Department of Health and Human Services. National Cancer Institute. What you need to know about™ brain tumors. Accessed April 14, 2011.

    Barnholtz-Sloan JS, Sloan AE, Schwartz AG. Cancer of the brain and other central nervous system. In: SEER Survival Monograph. National Cancer Institute. www.seer.cancer.gov/publications/survival/surv_brain.pdf. Accessed April 14, 2011.

    Nieder C, Grosu AL, Astner S, Molls M. Treatment of unresectable glioblastoma multiforme. Anticancer Res. 2005;25:4605-4610. PMID: 16334150 

Brain Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer 

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Brain Cancer

Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 

 

 

 

 

 

 

 

 

 

 

Bile Duct Cancer

Bile Duct Cancer Biography

Source(google.com.pk)

A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver where many small ducts collect bile, a fluid made by the liver to break down fats during digestion. The small ducts come together to form the right and left hepatic bile ducts, which lead out of the liver. The two ducts join outside the liver to become the common hepatic duct. The part of the common hepatic duct that is outside the liver is called the extrahepatic bile duct. The extrahepatic bile duct is joined by a duct from the gallbladder (which stores bile) to form the common bile duct. Bile is released from the gallbladder through the common bile duct into the small intestine when food is being digested.Anatomy of the extrahepatic bile duct. The extrahepatic bile duct is part of a network of small ducts in the liver that collects bile. Bile flows into the right and left hepatic ducts which join together to form the common hepatic duct. The extrahepatic bile duct is the part of the common hepatic duct that is outside the liver. Bile flows through the extrahepatic bile duct and into the cystic duct to the gallbladder where it is stored. When food is being digested, bile flows back through the cystic duct and into the common bile duct where it is released into the small intestine.

Read more: http://www.umgcc.org/gi_program/258011general-information-about-extrahepatic-bile-duct-cancer.htm#ixzz2SfiIDxpa

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

Bile Duct Cancer

 

 

 

 

 

 

 

 

 

Tongue Cancer Causes

Tongue Cancer Causes Biography

Source(google.com.pk)

Before you can understand tongue cancer, you have to understand what causes tongue cancer. Armed with that bit of knowledge you can begin to wade through the hundreds of thousands of articles about tongue cancer on the web and in print. Consider this your starting line in a long race to understanding.
What is Tongue Cancer?

Tongue cancer is a malignant oral cancer that normally starts in squamous cells on surface of tongue or the floor of mouth. Once cancer has taken over these cells, it can continue to spread throughout the mouth and metastasize in other organs in the body.

Usually, tongue cancer means cancer in the forward two-thirds of the tongue, meaning any cancer in the base of the tongue, or the back one-third, is actually throat cancer.
What are some Tongue Cancer Causes?

Smoking is a common tongue cancer cause * from imdocuk.com
It’s hard to pin down tongue cancer causes because sometimes people who do not fit any of the risk factors still get tongue cancer. However, most of the time people with tongue cancer do fit one or more of the common tongue cancer causes.

First, tongue cancer is not “catchable” or contagious in any way. There are studies that show a family history of cancer can increase a person’s risk for cancer, but that has nothing to do with exposure to a person with cancer.

Tongue cancer is twice as common in men than women, and most cases of tongue cancer are found in people over the age of 40, especially after 60. It is not normally a young person’s cancer because most things that cause tongue cancer only do so after long exposure or heavy use.

For example, the largest tongue cancer cause is the heavy use of tobacco products (smoking, chewing, or snuffing of any sort).. Alcohol consumption is also highly related to tongue cancer.
Studies have shown that the more alcohol consumed, the higher the risk of oral cancer. And 3 out of 4 people who have tongue cancer or another type of oral cancer smoke, consume large amounts of alcohol, or both smoke and drink regularly.

Put simply, the tongue can’t handle abuse from chemicals in tobacco and alcohol when used regularly or excessively.

Regular exposure to the sun without a sunscreen lip balm or other protection can increase the risk of oral cancers beginning on the lips and then spreading to the tongue.
If a person has already contracted another type of head or neck cancer, he or she has an increased risk for tongue cancer.

How can Tongue Cancer Causes be Avoided?
Be aware that tongue cancer is highly curable if it is caught early, so pay attention to your tongue! In the mean time, there are some things you can do to avoid tongue cancer causes and improve your oral health.

The biggest tongue cancer causes are smoking and drinking, thus taking steps to reduce or quit smoking and drinking alcohol would greatly lower your chances of oral cancer.

When going outside, use lip blam with sunscreen to prevent cancer on your lips. In general, eating more fruits and vegetables can improve your immune system and keep you from having as many health problems, including cancers.

Also, make sure you have good oral hygiene habits. Brushing your tongue regularly can keep your tongue healthy. The best tongue brush is the Orabrush. It removes bad breath causing bacteria and keeps your tongue from contracting harmful infections.

Though the Orabrush can’t guarantee you won’t have tongue cancer, it can improve the health of your tongue and help you avoid tongue cancer causes. Healthier tongues are happier tongues.

Lymphoma Cancer

Lymphoma Cancer Biography

Source(google.com.pk)

The lymphatic system is a tubular structure of industry in all parts of the body and is essential for fighting infections. The lymph is a colorless fluid containing white blood cells (lymphocytes) and transported through the lymphatic system.

There are several types of lymphoma, cancer and then answer a question, how to diagnose and treat lymphoma, is a big challenge. The most common type of lymphoma and that the term is used interchangeably disease Hodgkin, and the rest of the type known as non-Hodgkin lymphoma.

Diagnosis:

Although there are many symptoms of lymphoma cancer, but may be similar to another disease, which renders possible the diagnosis of lymphoma.

Some symptoms are:

Swollen lymph nodes
Fatigue
Weight loss
Relapsing Fever
Night sweats

When a patient develops symptoms, he / she is a doctor, can perform the diagnostic procedure for confirming the disease. The diagnosis is based on:

The physical examination of the patient
Search the extensive personal and family history
The physical examination of lymph node abnormalities
Biopsy tests to confirm the malignancy of lymph node
Radiographs of the chest with a swollen lymph glands in the chest to monitor
Magnetic Resonance Imaging (MRI) or computed tomography (CT),
Ultrasound

After the diagnosis is cancer, and lymphoma is detected, the patient may undergo a series of tests to detect the correct phase of the disease.

Cancer:

Radiotherapy – radiation X-ray or similar strong can be used for lymphoma cancer. The rays aimed at the death of cancer cells, with internal or external radiotherapy. However, non-pregnant women eligible for the delivery of radiotherapy.

Chemotherapy – This treatment uses anticancer drugs to destroy cancer cells in the lymphatic system. The treatment can be administered, orally or intravenously in the immediate placement of cerebrospinal fluid. While chemotherapy can be observed in pregnant women is closely linked to eliminate any risk to the fetus to be seen.

Vaccine Therapy – This is a new treatment technique used to treat lymphoma. This technique aims to boost the body’s immunity to tumor cells. The drugs used to restore the immune system and stimulate protection against malignant tumors.

High dose chemotherapy with stem cell transplantation is another treatment option in recent years considered. The technique of replacing damaged blood forming stem cells from the patient’s stem cell donor.

Lymphoma cancer is a cancer of the lymphatic system affects the body. Approximately 35 and types of these tumors. So, how to diagnose and treat cancer lymphoma is a challenge for health professionals. Like any cancer, early diagnosis and prompt treatment is essential.

Bone Cancer

 Bone Cancer Biography

Source(google.com.pk)

Cancers can be discovered in bones in a number of different circumstances. When cancer is located in the bones, it is important to differentiate whether this cancer has spread from another site to the bones or whether the cancer originated in the bone tissue itself. This distinction is important not only for the sake of correct terminology, but also to accurately determine which treatment options are appropriate.

There are more than 100 types of cancer, and each cancer type is named for the organ or tissue in which it begins. When cancer cells spread, they may travel via the lymphatic channels to lymph nodes, or they may enter the bloodstream and travel to other organs or locations in the body that are distant from the site of the original, or primary, tumor. It is not unusual for cancers that originate in other parts of the body to spread to the bones and begin growing there. Certain types of cancers are particularly likely to spread to the bones. Cancers that commonly metastasize, or spread, to the bones include breast cancer, lung cancer, thyroid cancer, prostate cancer, and cancers of the kidney.

It is important to note that when these other types of cancer spread to the bone, they are still named for the tissue or organ where they arose and are not termed "bone" cancer. For example, breast cancer that has spread to the bones is referred to as metastatic breast cancer and not bone cancer.

In contrast to cancers which have spread to the bone, true bone cancers are tumors that arise from the tissues of the bones. These cancers, called primary bone cancers, are quite rare in comparison to cancers that have spread to the bones.

True bone cancer affects over 2,000 people in the United States each year. It is found most often in the bones of the arms and legs, but it can occur in any bone. Children and young people are more likely than adults to develop bone cancer. The symptoms of bone cancer tend to develop slowly and depend on the type, location, and size of the tumor. Pain is the most frequent symptom of bone cancer, but sometimes a lump on the bone can be felt through the skin.

Bone cancers are known as sarcomas. There are several types of sarcomas of bone, depending upon the kind of bone tissue where the tumor developed. The most common types of primary bone cancer are osteosarcoma, Ewing's sarcoma, and chondrosarcoma.

Osteosarcoma usually occurs between ages 10 and 25 and is more common in males than in females. Osteoosarcoma is most commonly found in the long bones of the arms or legs. Ewing's sarcoma is a tumor most commonly seen in people between 10 and 25 years of age that develops in the shaft (middle portion) of large bones, such as the hip bones, the long bones of the legs and upper arms, and the ribs. Chondrosarcoma is the bone tumor that is found mainly in adults. Chondrosarcoma arises from cartilage, the tissue located around the joints. Other, more rare types of bone cancer include fibrosarcoma, malignant giant cell tumor, and chordoma.

The treatment and prognosis of bone cancer depend upon multiple factors including the type and extent of the cancer, the patient's age and overall health status. Bone cancer may be treated with surgery, radiation therapy, chemotherapy, or a combination of these. Treatment for cancer that has spread to the bones (metastatic cancer) depends on the type of cancer (the tissue where the cancer started) and the extent of the spread.

Finally, another type of cancer can arise from blood cells produced in the bone marrow. Leukemia, multiple myeloma, and lymphoma are cancers that arise from these cells. These are referred to as hematologic malignancies (cancers of blood cells) and are not types of bone cancer.